• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病量表综述:在医学实践中,是否需要一种新的多领域量表来评估治疗效果?

Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?

机构信息

Memory Center, CHU - University of Nice Sophia Antipolis, Hôpital de Cimiez, 4 av Victoria, 06000 Nice, France.

出版信息

Alzheimers Res Ther. 2010 Aug 26;2(4):24. doi: 10.1186/alzrt48.

DOI:10.1186/alzrt48
PMID:20796301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2949590/
Abstract

INTRODUCTION

The present review of Alzheimer's disease (AD) rating scales aims to outline the need for a new rating scale to be used in routine clinical practice for long-term medical care of AD patients. An ideal scale would be: 1) practical, easy and quick to administer for an experienced clinician; 2) validated for AD; 3) multi-domain: covering the AD-relevant areas of cognition, activities of daily living, behavior, communication/social interaction, and quality of life; 4) applicable to all AD severity stages; 5) able to monitor disease progression; and 6) sensitive to measure therapy effects.

METHODS

The National Library of Medicines' MEDLINE database was searched for the years 1981 to September 2008, using a set of keywords aiming to select instruments which cover at least some of the requirements for an ideal practical AD scale for therapy evaluation. Measures for AD staging and screening tests were not considered for review.

RESULTS

Of 1,902 articles resulting from the literature search, 68 relevant AD scales were identified. Most of them were scales that predominantly measure the severity of major dysfunctions in particular AD domains. Only five scales met some of the requirements for a practical multi-domain AD scale, but did not possess all required characteristics.

CONCLUSIONS

Despite the multitude of AD scales for various purposes, there remains a need for a new multi-domain and easy to administer AD scale for assessment of disease progression and response to therapy in daily medical practice.

摘要

简介

本综述旨在概述用于阿尔茨海默病(AD)常规临床实践长期医疗的新评级量表的需求。一个理想的量表将是:1)对于有经验的临床医生来说,实用、易于操作且快速;2)经 AD 验证;3)多领域:涵盖与 AD 相关的认知、日常生活活动、行为、沟通/社会互动和生活质量领域;4)适用于所有 AD 严重程度阶段;5)能够监测疾病进展;6)能够灵敏地衡量治疗效果。

方法

通过一组旨在选择至少涵盖理想实用 AD 量表用于治疗评估的部分要求的关键词,在 1981 年至 2008 年 9 月期间,对美国国立医学图书馆的 MEDLINE 数据库进行了搜索。未考虑 AD 分期和筛选测试的措施。

结果

从文献检索中得到 1902 篇文章,确定了 68 种相关的 AD 量表。其中大多数是主要测量特定 AD 领域中主要功能障碍严重程度的量表。只有 5 种量表符合实用多领域 AD 量表的一些要求,但不具备所有必需的特征。

结论

尽管有许多用于各种目的的 AD 量表,但仍需要一种新的多领域且易于管理的 AD 量表,用于评估疾病进展和日常医疗实践中的治疗反应。

相似文献

1
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?阿尔茨海默病量表综述:在医学实践中,是否需要一种新的多领域量表来评估治疗效果?
Alzheimers Res Ther. 2010 Aug 26;2(4):24. doi: 10.1186/alzrt48.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
4
5
How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?我们如何才能提高在阿尔茨海默病中用疾病修饰药物进行的随机临床试验的结果在临床实践中的转化?
Neurodegener Dis. 2014;13(2-3):197-9. doi: 10.1159/000353748. Epub 2013 Aug 7.
6
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.阿尔茨海默病轻度与中度阶段:胆碱酯酶抑制剂治疗常规临床环境中的三年结局
Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.
7
A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impact.阿尔茨海默病患者生活质量综述。第一部分:评估疾病影响的相关问题。
Pharmacoeconomics. 1998 Nov;14(5):499-530. doi: 10.2165/00019053-199814050-00004.
8
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
9
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].[简短认知功能测试组合(B2C)的验证。在精神科实践中筛查阿尔茨海默病和抑郁症的价值]
Encephale. 2003 May-Jun;29(3 Pt 1):266-72.
10
Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice.阿尔茨海默病相关结局量表的验证:一种用于日常医疗实践的新型多领域评估。
Alzheimers Res Ther. 2011 Jul 6;3(5):27. doi: 10.1186/alzrt89.

引用本文的文献

1
Psychometric evaluation of the Norwegian version of the Threadgold Communication Tool.挪威版Threadgold沟通工具的心理测量评估
Int J Nurs Stud Adv. 2025 Aug 6;9:100405. doi: 10.1016/j.ijnsa.2025.100405. eCollection 2025 Dec.
2
The Impact of Type 2 Diabetes Mellitus on the Severity of Alzheimer's Disease in Hispanic Populations in the Rio Grande Valley: A Pilot Retrospective Chart Review.2型糖尿病对里奥格兰德河谷西班牙裔人群阿尔茨海默病严重程度的影响:一项回顾性图表审查试点研究
Cureus. 2025 Jun 15;17(6):e86086. doi: 10.7759/cureus.86086. eCollection 2025 Jun.
3
Predictors of Cognitive Decline in Alzheimer's Disease: A Longitudinal Bayesian Analysis.阿尔茨海默病认知衰退的预测因素:一项纵向贝叶斯分析
Medicina (Kaunas). 2025 May 11;61(5):877. doi: 10.3390/medicina61050877.
4
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2.测量ADMET和ADMET 2中冷漠症状的临床相关变化。
Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.
5
A Severe Alzheimer's Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant.一名重度阿尔茨海默病患者通过静脉注射间充质干细胞移植得到改善。
Case Rep Neurol Med. 2024 Jul 15;2024:8353492. doi: 10.1155/2024/8353492. eCollection 2024.
6
Shortening the Alzheimer's disease assessment scale cognitive subscale.缩短阿尔茨海默病评估量表认知分量表。
Eur Psychiatry. 2024 Feb 23;67(1):e19. doi: 10.1192/j.eurpsy.2024.14.
7
Neural Underpinnings of Learning in Dementia Populations: A Review of Motor Learning Studies Combined with Neuroimaging.痴呆人群学习的神经基础:结合神经影像学的运动学习研究综述。
J Cogn Neurosci. 2024 May 1;36(5):734-755. doi: 10.1162/jocn_a_02116.
8
Development of the Forman Alzheimer's disease scale.福尔曼阿尔茨海默病量表的开发。
Heliyon. 2023 Nov 11;9(12):e22246. doi: 10.1016/j.heliyon.2023.e22246. eCollection 2023 Dec.
9
A task force for diagnosis and treatment of people with Alzheimer's disease in Latin America.拉丁美洲阿尔茨海默病患者诊断与治疗特别工作组。
Front Neurol. 2023 Jul 11;14:1198869. doi: 10.3389/fneur.2023.1198869. eCollection 2023.
10
Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS.肌萎缩侧索硬化症失能多维评定量表的制定,以衡量肌萎缩侧索硬化症的疾病进展。
Neurology. 2023 Aug 8;101(6):e602-e612. doi: 10.1212/WNL.0000000000207483. Epub 2023 Jun 13.

本文引用的文献

1
Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.严重损伤成套测验语言量表:一种用于阿尔茨海默病患者的语言评估工具。
Alzheimers Dement. 2009 Sep;5(5):375-9. doi: 10.1016/j.jalz.2009.04.1236.
2
Scales as outcome measures for Alzheimer's disease.作为阿尔茨海默病结局指标的量表。
Alzheimers Dement. 2009 Jul;5(4):324-39. doi: 10.1016/j.jalz.2009.05.667.
3
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement.痴呆症日常生活能力量表的系统评价:仍有改进空间
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):7-12. doi: 10.1136/jnnp.2008.155838.
4
Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials.关于临床试验中神经精神科问卷的管理与评分的评论
Alzheimers Dement. 2008 Nov;4(6):390-4. doi: 10.1016/j.jalz.2008.09.002.
5
A neuropsychological test battery for use in Alzheimer disease clinical trials.用于阿尔茨海默病临床试验的一套神经心理学测试
Arch Neurol. 2007 Sep;64(9):1323-9. doi: 10.1001/archneur.64.9.1323.
6
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care.阿尔茨海默病治疗指南:重新定义初级保健中的认知
Prim Care Companion J Clin Psychiatry. 2007;9(2):113-21. doi: 10.4088/pcc.v09n0205.
7
Global measures: utility in defining and measuring treatment response in dementia.整体测量指标:在痴呆症治疗反应的定义和测量中的效用
Int Psychogeriatr. 2007 Jun;19(3):421-56. doi: 10.1017/S1041610207005261.
8
Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination.测量老年人的认知变化:简易精神状态检查表的可靠变化指数
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1298-303. doi: 10.1136/jnnp.2006.109074. Epub 2007 Apr 18.
9
ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.ADCS预防工具项目:在痴呆症预防临床试验中对社区居住老年个体的日常生活工具性活动进行评估。
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S152-69. doi: 10.1097/01.wad.0000213873.25053.2b.
10
Development and testing of a new outcome measure of relationship between patients with Alzheimer's disease and their partners.一种用于衡量阿尔茨海默病患者与其伴侣关系的新结果指标的开发与测试。
Am J Alzheimers Dis Other Demen. 2006 Aug-Sep;21(4):249-57. doi: 10.1177/1533317506290665.